knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 00:36:53 - browse：8188

ADAM FEUERSTEIN/STAT

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up here.

CHICAGO — It’s only Day 2, but the ASCO meeting is already in full force. That means hordes of oncologists filling the halls, reams of data streaming through the meeting, and incredibly long lines for even the worst food. And STAT reporters Angus Chen, Adam Feuerstein, and Matthew Herper are in the thick of it – on the heels of STAT’s own in-person event here, which was standing room only and came with its own share of thrills, chills, and not a little bit of audience laughter. More on that in a bit.

Here’s a rundown of some of the big news from the first 24 hours of the meeting which, due to some weird kind of relativistic time dilation, represents about a week for our intrepid reporters.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Treatments for cramps don't cut it. Why aren't there better options?

WSS

Be careful with at

Why getting cancer drugs just got harder for rural patients

Megan Rapinoe shares emotional post following US Women's World Cup exit

Patients, digital health players weigh in on FTC's data privacy plan

YouTube cracks down on misinformation on cancer treatment

Maui wildfire now ranks as the fifth

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Kenai launches with $82 million for Parkinson’s stem cell therapy

BioMarin wins approval for gene therapy to treat hemophilia A

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

How one medical school became remarkably diverse

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

BioMarin wins approval for gene therapy to treat hemophilia A

Mark Cuban is blaming the wrong people for high drug costs

Trump demands the U.S. pay no more for drugs than other countries … again

Megan Rapinoe shares emotional post following US Women's World Cup exit

focus

Medical device lobby: We're tired of waiting on Medicare coverage

After Optum profits sink, UnitedHealth makes changes

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

What to know about the judge who will handle the Trump case

Patients, digital health players weigh in on FTC's data privacy plan

focus

entertainment

focus

explore